cota-pattern

Bringing clarity to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.
cota-pattern

Our Approach

We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.

Together, we can bring clarity to cancer care.

#6846 - COTA Healthcare homepage redesign - Providers

Providers

We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.

#6846 - COTA Healthcare homepage redesign - Payers

Payers

We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.

#6846 - COTA Healthcare homepage redesign - Life Sciences

Life Sciences

Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.

Using Real World Data to Improve Blood Cancer Treatments with Dr. Gwen Nichols

Almost 10% of the world’s population suffers from a type of blood cancer. And despite popular opinion, there are actually hundreds of different types of blood cancer, not just leukemia and lymphoma.

But are we doing everything in our power when developing clinical trials to improve cancer treatment? Could we include diversity and make trials more accessible to everyone? Dr. Gwen Nichols thinks we have more work to do in the blood cancer space.

COTA Survey Report

Study: Cancer Patients and Their Families Frustrated with Slow Pace of Drug and Treatment Innovation

COTA announced findings from a study that found 66% of cancer patients and families surveyed think the speed of clinical trials for cancer treatments remains far too slow. Read more of the findings from the study, which surveyed 1,110 Americans who’ve either had cancer or who’ve had someone in their immediate family with cancer.

Latest Resources

FDA

Real-World Data Champion Robert Califf Nominated for FDA Commissioner

Dr. Califf is a staunch advocate for the use of real-world data (RWD) and real-world evidence (RWE) in the clinical trial ecosystem, with a long history of leveraging RWD and RWE to transform the life sciences community.

COTA Collaborates with University of Chicago Medicine and UT Southwestern on Research To Be Presented at the American Society for Hematology’s Annual Meeting & Exposition

Four abstracts will be showcased at the American Society for Hematology’s (ASH) Annual Meeting & Exposition from December 11–14, 2021, in Atlanta, Georgia. COTA has the most comprehensive hematology oncology real-world data that is curated under the close guidance of leading oncologists and hematology specialists.

Rewriting the Oncology Patient’s Journey with Real-World Data

Life science stakeholders are committed to making the path to positive outcomes less frightening and convoluted for patients. With breakthrough treatments and innovative therapies targeted to the toughest of cancers, the industry has made significant progress with guiding patients toward longer, healthier lives.

Let’s work together to transform cancer care.

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.